XPC and lung carcinoma: The overexpression of XPC reduced the cytotoxic effect of platinum-based chemotherapeutic drugs such as cisplatin and rendered lung cancer cells resistant to the platinum-based chemotherapeutic drugs (Teng et al., 2019; Liu et al., 2020).